Matches in SemOpenAlex for { <https://semopenalex.org/work/W2244952346> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2244952346 endingPage "4025" @default.
- W2244952346 startingPage "4025" @default.
- W2244952346 abstract "4025 Background: Cumulative sNT is the dose-limiting toxicity of oxaliplatin which commonly leads to early discontinuation of oxaliplatin-based therapy in the palliative and adjuvant setting. We recently demonstrated the protective effect of CaMg against oxaliplatin-induced sNT as assessed by NCI-CTC (Nikcevich ASCO 2008). It is unclear, though, if CaMg reduced acute and/or chronic, cumulative sNT. Methods: 104 pts with colon cancer undergoing adjuvant therapy with FOLFOX were randomized to IV CaMg (1g calcium gluconate plus 1g magnesium sulfate pre- and post-oxaliplatin) or placebo (PL) in a double-blinded manner. NCI-CTC, an oxaliplatin-specific sNT scale and patient-reported outcome (PRO) questionnaires were used to differentially assess the effect of CaMg on acute (effect on sNT on days 1–4 after oxaliplatin) and chronic sNT (area between curves over whole course of therapy). Results: A total of 102 pts (50 CaMg, 52 PL; 96 mFOLFOX6, 6 FOLFOX4) were available for analysis. Apart from a strong reduction in muscle cramps with CaMg (p=0.002), no difference was found between CaMg and PL in PRO with regard to items reflecting acute sNT (e.g. sensitivity to cold, swallowing of cold liquids, throat discomfort) on days 1–4 after oxaliplatin of any treatment cycle. In contrast, CaMg was able to significantly reduce cumulative sNT in form of numbness in fingers (p=0.02), impaired ability to button shirts (p=0.05), tingling in fingers (p=0.06), and muscle cramps over the course of therapy (p=0.01). Conclusions: In our phase III, placebo-controlled trial, CaMg was able to significantly reduce chronic, cumulative sNT related to oxaliplatin as evaluated by specific PRO questionnaires. No effect was noted on phenomena associated with acute sNT. CaMg can be recommended as neuroprotectant against oxaliplatin-related chronic sNT, oxaliplatin's dose-limiting toxicity. [Table: see text]" @default.
- W2244952346 created "2016-06-24" @default.
- W2244952346 creator A5008767553 @default.
- W2244952346 creator A5031000802 @default.
- W2244952346 creator A5031202583 @default.
- W2244952346 creator A5056482863 @default.
- W2244952346 creator A5057458005 @default.
- W2244952346 creator A5061188498 @default.
- W2244952346 creator A5072257104 @default.
- W2244952346 creator A5075955222 @default.
- W2244952346 creator A5078543517 @default.
- W2244952346 creator A5081957836 @default.
- W2244952346 date "2009-05-20" @default.
- W2244952346 modified "2023-09-25" @default.
- W2244952346 title "Evaluation of the effect of intravenous calcium and magnesium (CaMg) on chronic and acute neurotoxicity associated with oxaliplatin: Results from a placebo-controlled phase III trial" @default.
- W2244952346 doi "https://doi.org/10.1200/jco.2009.27.15_suppl.4025" @default.
- W2244952346 hasPublicationYear "2009" @default.
- W2244952346 type Work @default.
- W2244952346 sameAs 2244952346 @default.
- W2244952346 citedByCount "5" @default.
- W2244952346 countsByYear W22449523462015 @default.
- W2244952346 crossrefType "journal-article" @default.
- W2244952346 hasAuthorship W2244952346A5008767553 @default.
- W2244952346 hasAuthorship W2244952346A5031000802 @default.
- W2244952346 hasAuthorship W2244952346A5031202583 @default.
- W2244952346 hasAuthorship W2244952346A5056482863 @default.
- W2244952346 hasAuthorship W2244952346A5057458005 @default.
- W2244952346 hasAuthorship W2244952346A5061188498 @default.
- W2244952346 hasAuthorship W2244952346A5072257104 @default.
- W2244952346 hasAuthorship W2244952346A5075955222 @default.
- W2244952346 hasAuthorship W2244952346A5078543517 @default.
- W2244952346 hasAuthorship W2244952346A5081957836 @default.
- W2244952346 hasConcept C121608353 @default.
- W2244952346 hasConcept C126322002 @default.
- W2244952346 hasConcept C141071460 @default.
- W2244952346 hasConcept C142724271 @default.
- W2244952346 hasConcept C151032500 @default.
- W2244952346 hasConcept C204787440 @default.
- W2244952346 hasConcept C27081682 @default.
- W2244952346 hasConcept C2778260052 @default.
- W2244952346 hasConcept C2778715236 @default.
- W2244952346 hasConcept C2780962732 @default.
- W2244952346 hasConcept C42219234 @default.
- W2244952346 hasConcept C526805850 @default.
- W2244952346 hasConcept C71924100 @default.
- W2244952346 hasConcept C90924648 @default.
- W2244952346 hasConceptScore W2244952346C121608353 @default.
- W2244952346 hasConceptScore W2244952346C126322002 @default.
- W2244952346 hasConceptScore W2244952346C141071460 @default.
- W2244952346 hasConceptScore W2244952346C142724271 @default.
- W2244952346 hasConceptScore W2244952346C151032500 @default.
- W2244952346 hasConceptScore W2244952346C204787440 @default.
- W2244952346 hasConceptScore W2244952346C27081682 @default.
- W2244952346 hasConceptScore W2244952346C2778260052 @default.
- W2244952346 hasConceptScore W2244952346C2778715236 @default.
- W2244952346 hasConceptScore W2244952346C2780962732 @default.
- W2244952346 hasConceptScore W2244952346C42219234 @default.
- W2244952346 hasConceptScore W2244952346C526805850 @default.
- W2244952346 hasConceptScore W2244952346C71924100 @default.
- W2244952346 hasConceptScore W2244952346C90924648 @default.
- W2244952346 hasIssue "15_suppl" @default.
- W2244952346 hasLocation W22449523461 @default.
- W2244952346 hasOpenAccess W2244952346 @default.
- W2244952346 hasPrimaryLocation W22449523461 @default.
- W2244952346 hasRelatedWork W2023304218 @default.
- W2244952346 hasRelatedWork W2136301243 @default.
- W2244952346 hasRelatedWork W2136984368 @default.
- W2244952346 hasRelatedWork W2240523837 @default.
- W2244952346 hasRelatedWork W2383258263 @default.
- W2244952346 hasRelatedWork W2973076369 @default.
- W2244952346 hasRelatedWork W309999826 @default.
- W2244952346 hasRelatedWork W3137837473 @default.
- W2244952346 hasRelatedWork W3166487704 @default.
- W2244952346 hasRelatedWork W4205913792 @default.
- W2244952346 hasVolume "27" @default.
- W2244952346 isParatext "false" @default.
- W2244952346 isRetracted "false" @default.
- W2244952346 magId "2244952346" @default.
- W2244952346 workType "article" @default.